Dr. Wadleigh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
450 Brookline Ave
Boston, MA 02215Phone+1 617-632-6685Fax+1 617-582-8202- Is this information wrong?
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2001 - 2004
Duke University HospitalResidency, Internal Medicine, 1998 - 2001
Duke University School of MedicineClass of 1998
Certifications & Licensure
MA State Medical License 2004 - 2025
NC State Medical License 1998 - 2001- American Board of Internal Medicine Hematology
Clinical Trials
- Vaccine Therapy and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Start of enrollment: 2005 Sep 01
- Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive Leukemia Start of enrollment: 2008 Jun 01
- A Phase 1/2 Study of Oral SB1518 in Subjects With Chronic Idiopathic Myelofibrosis Start of enrollment: 2008 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsPhase 1b trial of tagraxofusp in combination with azacitidine with or without venetoclax in acute myeloid leukemia.Lane, A., Garcia, J., Raulston, E., Garzon, J., Galinsky, I., Baxter, E., Leonard, R., DeAngelo, D., Luskin, M., Reilly, C., Stahl, M., Stone, R., Vedula, R., Wadleigh...> ;Blood Advances. 2024 Feb 13
- A randomized, double-blind study of zinpentraxin alfa in patients with myelofibrosis who were previously treated with or ineligible for ruxolitinib: Stage 2 of a phase...Verstovsek, S., Talpaz, M., Wadleigh, M., Isidori, A., Te Boekhorst, P., Savona, M., Bose, P., Pozdnyakova, O., Mesa, R., El-Galaly, T., O'Sullivan, J., Gamel, K., Hig...> ;Haematologica. 2024 Jan 25
- 4 citationsTreatment completion, asparaginase completion, and oncologic outcomes among children, adolescents and young adults with acute lymphoblastic leukemia treated with DFCI ...Valtis, Y., Flamand, Y., Shimony, S., Place, A., Silverman, L., Vrooman, L., Brunner, A., Sallan, S., Wadleigh, M., Stone, R., DeAngelo, D., Luskin, M.> ;Leukemia. 2024 Mar 1
- Join now to see all
Abstracts/Posters
- Sleep Disturbance Among Patients with Myelodysplastic Syndromes and Acute LeukemiaMartha Wadleigh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Patient-Reported Outcome Results from the U.S. Life after Stopping TKIs (LAST) Study in Patients with Chronic Myeloid LeukemiaMartha Wadleigh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical, Clinical, and Correlative StudiesMartha Wadleigh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Press Mentions
Victor Paul Berardi, 69May 6th, 2020
6 Signs of Leukemia Every Woman Needs to KnowMarch 1st, 2017
Professional Memberships
- Member
Hospital Affiliations
Dana-Farber Cancer InstituteBoston, Massachusetts
Brigham and Women's HospitalBoston, Massachusetts
Salem HospitalSalem, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
